DPP-4 inhibitor and alpha-glucosidase inhibitor equally improve endothelial function in patients with type 2 diabetes (EDGE study)

European Heart Journal ◽

10.1093/eurheartj/eht308.p1432 ◽

2013 ◽

Vol 34 (suppl 1) ◽

pp. P1432-P1432

Author(s):

H. Kihara ◽

K. Nakamura ◽

H. Oe ◽

K. Shimada ◽

S. Fukuda ◽

...

Keyword(s):

Type 2 Diabetes ◽

Endothelial Function ◽

Glucosidase Inhibitor ◽

Alpha Glucosidase

Download Full-text

DPP-4 inhibitor and alpha-glucosidase inhibitor equally improve endothelial function in patients with type 2 diabetes: EDGE study

Cardiovascular Diabetology ◽

10.1186/s12933-014-0110-2 ◽

2014 ◽

Vol 13 (1) ◽

Author(s):

Kazufumi Nakamura ◽

Hiroki Oe ◽

Hajime Kihara ◽

Kenei Shimada ◽

Shota Fukuda ◽

...

Keyword(s):

Type 2 Diabetes ◽

Endothelial Function ◽

Glucosidase Inhibitor ◽

Alpha Glucosidase

Download Full-text

Effects of the Alpha Glucosidase Inhibitor Acarbose on Endothelial Function after a Mixed Meal in Newly Diagnosed Type 2 Diabetes

Hormone and Metabolic Research ◽

10.1055/s-0028-1103276 ◽

2008 ◽

Vol 41 (02) ◽

pp. 104-108 ◽

Author(s):

F. Pistrosch ◽

F. Schaper ◽

J. Passauer ◽

C. Koehler ◽

S. Bornstein ◽

...

Keyword(s):

Type 2 Diabetes ◽

Endothelial Function ◽

Newly Diagnosed ◽

Glucosidase Inhibitor ◽

Alpha Glucosidase

Download Full-text

Effect of Miglitol, an ^|^alpha;-Glucosidase Inhibitor, on Postprandial Glucose and Lipid Metabolism in Patients with Type 2 Diabetes

The Showa University Journal of Medical Sciences ◽

10.15369/sujms.23.217 ◽

2011 ◽

Vol 23 (4) ◽

pp. 217-225

Author(s):

Yukiyo KANEKO ◽

Koji KUBOKI ◽

Naoki HIROI ◽

Takehiko WATANABE ◽

Chiaki NISHIMURA ◽

...

Keyword(s):

Type 2 Diabetes ◽

Lipid Metabolism ◽

Postprandial Glucose ◽

Glucosidase Inhibitor ◽

Glucose And Lipid Metabolism ◽

Alpha Glucosidase

Download Full-text

Combination Therapy of Alpha-Glucosidase Inhibitor, Thiazolidinedione and Sodium Glucose Co-Transporter-2 Inhibitor in Japanese Type 2 Diabetes Patients

Journal of Endocrinology and Metabolism ◽

10.14740/jem708 ◽

2020 ◽

Vol 10 (6) ◽

pp. 167-172

Author(s):

Masataka Kusunoki ◽

Naomi Wakazono ◽

Kazuhiko Tsutsumi ◽

Yoshiharu Oshida ◽

Tesuro Miyata

Keyword(s):

Type 2 Diabetes ◽

Combination Therapy ◽

Glucosidase Inhibitor ◽

Alpha Glucosidase ◽

Diabetes Patients

Download Full-text

Effect of Acarbose, an Alpha-Glucosidase Inhibitor, on Serum Lipoprotein Lipase Mass Levels and Common Carotid Artery Intima-Media Thickness in Type 2 Diabetes Mellitus Treated by Sulfonylurea

Journal of Atherosclerosis and Thrombosis ◽

10.5551/jat.e549 ◽

2008 ◽

Vol 15 (3) ◽

pp. 154-159 ◽

Author(s):

Tomokazu Oyama ◽

Atsuhito Saiki ◽

Kei Endoh ◽

Noriko Ban ◽

Daizi Nagayama ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Carotid Artery ◽

Common Carotid Artery ◽

Intima Media Thickness ◽

Serum Lipoprotein ◽

Glucosidase Inhibitor ◽

Alpha Glucosidase

Download Full-text

Development of Mulberry Leaf Product with .ALPHA.-Glucosidase Inhibitor for the Prevention of Type 2 Diabetes Mellitus

Nippon Shokuhin Kagaku Kogaku Kaishi ◽

10.3136/nskkk.57.57 ◽

2010 ◽

Vol 57 (2) ◽

pp. 57-62 ◽

Author(s):

Toshiyuki Kimura

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Glucosidase Inhibitor ◽

Mulberry Leaf ◽

Alpha Glucosidase

Download Full-text

Effect of pioglitazone on muscle sympathetic nerve activity in type 2 diabetes mellitus with alpha-glucosidase inhibitor

Autonomic Neuroscience ◽

10.1016/j.autneu.2010.05.003 ◽

2010 ◽

Vol 158 (1-2) ◽

pp. 86-91 ◽

Author(s):

Daisuke Kobayashi ◽

Masayuki Takamura ◽

Hisayoshi Murai ◽

Soichiro Usui ◽

Tatsunori Ikeda ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Sympathetic Nerve ◽

Sympathetic Nerve Activity ◽

Muscle Sympathetic Nerve Activity ◽

Nerve Activity ◽

Glucosidase Inhibitor ◽

Alpha Glucosidase

Download Full-text

Efficacy and safety of the dipeptidyl peptidase‐4 inhibitor sitagliptin compared with alpha‐glucosidase inhibitor in Japanese patients with type 2 diabetes inadequately controlled on metformin or pioglitazone alone (Study for an Ultimate Combination Therapy to Control Diabetes with Sitagliptin‐1): A multicenter, randomized, open‐label, non‐inferiority trial

Journal of Diabetes Investigation ◽

10.1111/jdi.12282 ◽

2014 ◽

Vol 6 (2) ◽

pp. 182-191 ◽

Author(s):

Hidetaka Yokoh ◽

Kazuki Kobayashi ◽

Yasunori Sato ◽

Minoru Takemoto ◽

Daigaku Uchida ◽

...

Keyword(s):

Type 2 Diabetes ◽

Japanese Patients ◽

Efficacy And Safety ◽

Dipeptidyl Peptidase 4 ◽

Glucosidase Inhibitor ◽

Dipeptidyl Peptidase 4 Inhibitor ◽

Alpha Glucosidase ◽

Control Diabetes

Download Full-text

Sitagliptin but not alpha glucosidase inhibitor reduced the serum soluble CD163, a marker for activated macrophage, in individuals with type 2 diabetes mellitus

Diabetes Research and Clinical Practice ◽

10.1016/j.diabres.2017.02.010 ◽

2017 ◽

Vol 126 ◽

pp. 138-143 ◽

Author(s):

Akiko Hattori ◽

Minoru Takemoto ◽

Hirotake Tokuyama ◽

Masaya Koshizaka ◽

Koutaro Yokote

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Soluble Cd163 ◽

Glucosidase Inhibitor ◽

Activated Macrophage ◽

Alpha Glucosidase

Download Full-text

Alpha-glucosidase inhibitor, acarbose, improves glycamic control and reduces body weight in type 2 diabetes: Findings on indian patients from the pooled data analysis

Indian Journal of Endocrinology and Metabolism ◽

10.4103/2230-8210.119634 ◽

2013 ◽

Vol 17 (7) ◽

pp. 307 ◽

Author(s):

Sanjay Kalra ◽

RK Sahay ◽

O Schnell ◽

W. H. H. Sheu ◽

W Grzeszczak ◽

...

Keyword(s):

Type 2 Diabetes ◽

Body Weight ◽

Data Analysis ◽

Pooled Data ◽

Glucosidase Inhibitor ◽

Indian Patients ◽

Alpha Glucosidase

Download Full-text